Eagle Pharmaceuticals, Inc. to Present at September Investor Conferences

WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)-- Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or “the Company”) today announced that Scott Tarriff, Chief Executive Officer, and Pete Meyers, Chief Financial Officer, will present at two investor conferences in September as follows:

The presentations will be webcast live at the aforementioned time, and archived for 30 days thereafter, via the Company’s website at www.eagleus.com, under the Investors Section.

About Eagle Pharmaceuticals, Inc.

Eagle is a specialty pharmaceutical company focused on developing and commercializing injectable products that address the shortcomings, as identified by physicians, pharmacists and other stakeholders, of existing commercially successful injectable products. Eagle’s strategy is to utilize the FDA's 505(b)(2) regulatory pathway. Additional information is available on the Company’s website at www.eagleus.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20170906005603/en/

Investor Relations for Eagle Pharmaceuticals, Inc:
In-Site Communications, Inc
Lisa M. Wilson, 212-452-2793
[email protected]

Source: Eagle Pharmaceuticals, Inc.

You May Also Be Interested In

• Cantor Fitzgerald Starts Milestone Pharmaceuticals (MIST) at Overweight
• Sui Price Prediction: Can SUI Hit $5 as Next Crypto To Explode AlphaPepe Builds Four Products Pre-Launch?
• Bitcoin Price Prediction: BTC Eyes $100K Comeback as AlphaPepe Buyers Countdown to the 4th CEX Reveal